INTERVIEW: High hopes for new HIV vaccine
INTERVIEW: High hopes for new HIV vaccine
The HIV Virus Source: Getty / RUSLANAS BARANAUSKAS/SCIENCE PHOTO LIBRARY
Researchers from the Fred Hutchinson Cancer Center in Seattle have tested a new HIV vaccine using mRNA, the technology behind many COVID-19 vaccines. Scientists say results from the early-stage clinical trial offer hope for significant progress in the global effort to develop a safe and effective HIV vaccine. For this episode of Weekend One on One, Angelica Waite has been speaking with Associate Professor Seth Cheetham, Deputy Director of BASE mRNA at the University of Queensland to learn more about the study, and what it means for HIV vaccine research
Share
Latest podcast episodes
Recommended for you
Leader in dementia research shares four ways you can reduce your risk
dementia awareness
Which states get an Anzac Day public holiday this year?
public holidays
The common medications that can become 'quite dangerous' on hot days
health and wellbeing
